COMMUNIQUÉS West-GlobeNewswire

-
Erasca Announces Three Presentations at the 2024 ASCO Annual Meeting
24/04/2024 -
Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million
24/04/2024 -
ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR™ Stereotactic System
24/04/2024 -
Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
24/04/2024 -
Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
24/04/2024 -
Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting
24/04/2024 -
Cidara Therapeutics Announces Divestiture of Rezafungin to Mundipharma* to Focus on Advancing the Clinical Development of Cloudbreak DFC Pipeline
24/04/2024 -
Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
24/04/2024 -
Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
24/04/2024 -
Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
24/04/2024 -
Madrigal Statement on the Passing of Dr. Stephen Harrison
24/04/2024 -
Cytokinetics to Announce First Quarter Results on May 8, 2024
24/04/2024 -
InnovAge Launches PACE Center in Los Angeles, Helping Seniors Live Independently with High-Quality Care
24/04/2024 -
Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event
24/04/2024 -
SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
24/04/2024 -
LTC ACO Welcomes New Chief Operating Officer
24/04/2024 -
Virbac : Public release of Virbac Annual Report at 31 December 2023 (ESEF format)
24/04/2024 -
Virbac : Communiqué de mise à disposition du Rapport Annuel au format ESEF au 31 décembre 2023
24/04/2024 -
Basilea shareholders approve all proposals of the board of directors at the annual general meeting
24/04/2024
Pages